🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06128317
Recruiting Observational

Myocardial Infarction Registry

NCT06128317 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2014-08-01
Last updated
2023-11-14

Condition(s) studied

Acute Coronary Syndrome

Investigational drug(s) / intervention(s)

no intervention is intended.

no intervention is intended.: no intervention is intended.

Study summary

The single-center MIR-registry was created to assess real-world prevalence, demographic characteristics and management of patients with acute coronary syndrome presenting in the emergency department (ED) of University of Heidelberg.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: The study will include consecutive patients who present to the cardiology emergency department at Heidelberg University Hospital with symptoms of acute coronary syndrome or a troponin increase (hs-TnT \>14 ng/L). Additional inclusion criteria are a minimum age of 18 years and providing informed consent through written consent to participate in the study. The following medical conditions are intended to be distinguished from one another: * Acute myocardial infarction * Unstable angina pectoris * Myocarditis * Heart failure * Cardiomyopathies * Pulmonary embolism * Renal insufficiency * Supraventricular and ventricular tachycardias * Hypertensive crisis * Non-cardiac chest pain Exclusion Criteria: Exclusion criteria are defined according to GCP (Good Clinical Practice), i.e., mental illnesses/dementia (lack of capacity to provide informed consent), pregnancy/breastfeeding, as well as acute conditions requiring immediate treatment (e.g., cardiogenic shock).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Hospital of Heidelberg Heidelberg Baden-Wurttemberg Recruiting

More University Hospital Heidelberg trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06128317 on ClinicalTrials.gov ↗ ← All trials in Germany